Document Detail


Civil society strategy for the compulsory licensing of lopinavir/ritonavir: the Brazilian case.
MedLine Citation:
PMID:  19297771     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The flexibilities in the TRIPS Agreement (Trade Related Aspects of Intellectual Property) have been very useful in lowering the prices of antiretrovirals (ARVs) in Brazil. In this article, based on several presentations made at the conference, Marcela Fogaça Vieira et al describe recent developments in Brazil, including the granting of a compulsory licence for efavirenz.
Authors:
Marcela Fogaça Vieira; Renata Reis; Gabriela Chaves
Publication Detail:
Type:  Newspaper Article    
Journal Detail:
Title:  HIV/AIDS policy & law review / Canadian HIV/AIDS Legal Network     Volume:  13     ISSN:  1712-624X     ISO Abbreviation:  -     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2009-03-06     Completed Date:  2009-03-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101249725     Medline TA:  HIV AIDS Policy Law Rev     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  80-1     Citation Subset:  X    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Brazil
Drug Approval / legislation & jurisprudence*
HIV Infections / drug therapy*
HIV Protease Inhibitors / administration & dosage,  economics,  therapeutic use*
Humans
Pyrimidinones / administration & dosage,  economics,  therapeutic use*
Ritonavir / administration & dosage,  economics,  therapeutic use*
Chemical
Reg. No./Substance:
0/HIV Protease Inhibitors; 0/Pyrimidinones; 0/Ritonavir; 192725-17-0/lopinavir

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Using strategic litigation to strengthen rights in southern Africa.
Next Document:  Abuses of women's rights in sexual and reproductive health-care settings.